These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 33930719

  • 1. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma.
    Park HJ, Byun JH, Kang JH, Kang HJ, Yu E, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN.
    Eur J Radiol; 2021 Jun; 139():109730. PubMed ID: 33930719
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A.
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS.
    AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
    [Abstract] [Full Text] [Related]

  • 4. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
    Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A.
    Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059
    [Abstract] [Full Text] [Related]

  • 5. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF.
    AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
    [Abstract] [Full Text] [Related]

  • 6. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
    Alamri TM, Cerny M, Al Shaikh M, Billiard JS, Olivié D, Chagnon M, Tang A.
    Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
    [Abstract] [Full Text] [Related]

  • 7. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A.
    AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
    [Abstract] [Full Text] [Related]

  • 8. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
    Auer TA, Walter-Rittel T, Geisel D, Schöning W, Schmelzle M, Müller T, Sinn B, Denecke T, Hamm B, Fehrenbach U.
    BMC Med Imaging; 2021 Feb 15; 21(1):28. PubMed ID: 33588783
    [Abstract] [Full Text] [Related]

  • 9. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    Kitao A, Matsui O, Yoneda N, Kita R, Kozaka K, Kobayashi S, Gabata T.
    AJR Am J Roentgenol; 2018 Aug 15; 211(2):347-357. PubMed ID: 29708786
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
    Bilreiro C, Soler JC, Ayuso JR, Caseiro-Alves F, Ayuso C.
    Radiol Med; 2021 Nov 15; 126(11):1379-1387. PubMed ID: 34287759
    [Abstract] [Full Text] [Related]

  • 11. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E, Amaddeo G, Pigneur F, Baranes L, Legou F, Mulé S, Zegai B, Roche V, Laurent A, Rahmouni A, Calderaro J, Luciani A.
    Eur Radiol; 2018 Oct 15; 28(10):4243-4253. PubMed ID: 29721686
    [Abstract] [Full Text] [Related]

  • 12. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    Kim TH, Woo S, Ebrahimzadeh S, McInnes MDF, Gerst SR, Do RK.
    AJR Am J Roentgenol; 2023 Jan 15; 220(1):28-38. PubMed ID: 35920706
    [Abstract] [Full Text] [Related]

  • 13. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS, Remer EM, Coppa CP, Obuchowski NA, Schneider E, Veniero JC.
    AJR Am J Roentgenol; 2012 Jan 15; 198(1):115-23. PubMed ID: 22194486
    [Abstract] [Full Text] [Related]

  • 14. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
    Sciarra A, Schmidt S, Pellegrinelli A, Maggioni M, Dondossola D, Pasquier J, Cigala C, Tosi D, Halkic N, Bulfamante G, Viale G, Bosari S, Balabaud C, Bioulac-Sage P, Sempoux C.
    Liver Int; 2019 Jan 15; 39(1):158-167. PubMed ID: 30218633
    [Abstract] [Full Text] [Related]

  • 15. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Vanhooymissen IJSML, Thomeer MG, Braun LMM, Gest B, van Koeverden S, Willemssen FE, Hunink M, De Man RA, Ijzermans JN, Dwarkasing RS.
    J Magn Reson Imaging; 2019 Mar 15; 49(3):700-710. PubMed ID: 30252977
    [Abstract] [Full Text] [Related]

  • 16. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
    Kim JW, Lee CH, Kim SB, Park BN, Park YS, Lee J, Park CM.
    J Magn Reson Imaging; 2017 Jun 15; 45(6):1599-1608. PubMed ID: 27726242
    [Abstract] [Full Text] [Related]

  • 17. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
    Lebert P, Adens-Fauquembergue M, Azahaf M, Gnemmi V, Behal H, Luciani A, Ernst O.
    Eur Radiol; 2019 Nov 15; 29(11):5742-5751. PubMed ID: 30993437
    [Abstract] [Full Text] [Related]

  • 18. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M, Fouladi DF, Pandey A, Ghasabeh MA, Pandey P, Varzaneh FN, Khoshpouri P, Shao N, Pan L, Grimm R, Kamel IR.
    J Magn Reson Imaging; 2018 Oct 15; 48(4):1080-1090. PubMed ID: 29630756
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis.
    Suh CH, Kim KW, Kim GY, Shin YM, Kim PN, Park SH.
    Eur Radiol; 2015 Apr 15; 25(4):950-60. PubMed ID: 25537979
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review.
    Guo Y, Li W, Cai W, Zhang Y, Fang Y, Hong G.
    Int J Med Sci; 2017 Apr 15; 14(7):668-674. PubMed ID: 28824299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.